The Latest Breaking News from Ro

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

NEW DELHI: Acting on the Himachal Pradesh High Court's order, the government has appointed Sports Authority of India’s (SAI) deputy director general in the Khelo India division, Mayank Srivastava, as an ‘independent observer’ to scrutinise the conduct of the much-delayed Boxing Federation of India (BFI) elections. World Boxing has also…

New Orleans chef Susan Spicer has been a regular contributor to the Taste of the NFL charity event at Super Bowl host cities around the country and is doing so in her hometown again this year

Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree.

As nearly $1 billion of venture capital dollars have been injected into weight-loss startups since 2023, companies are making unproven claims to attract customers. It’s a new twist on a story as old as the diet industry.

The tool, from telehealth company Ro, lets users report when they find the drug in stock and when there’s a shortage.

Villupuram MP D. Ravikumar raises concern over CCTV interruption in strong rooms during Lok Sabha vote counting.

Prominent candidates file nominations for Lok Sabha polls in Tamil Nadu, with dramatic events and heart-warming scenes.

According to a senior forest official, the episode began when a few ganja saplings were discovered in an abandoned building within the forest station premises.

Former Pakistan Prime Minister Imran Khan on Wednesday challenged the rejection of his nomination papers from NA-122 (Lahore) and NA-89 (Mianwali) in the election tribunals, Pakistan-based Dawn reported. Read further on Dynamite News: